Google Maps

NCT07742657

Overview

NCT ID: NCT07742657
Lead Sponsor: SuperBonsai Inc.INDUSTRY
Official Title: A Clinical Trial to Evaluate the Effects of Super Liver Liquid Drops on Gut Health, Digestive Comfort, and Daily Energy Levels
Brief Summary: This is a decentralized (fully virtual), single-group, open-label, prospective clinical trial evaluating the effects of Super Liver Liquid Drops, a liquid botanical dietary supplement, on gut health, digestive comfort, energy levels, and overall well-being over 12 weeks. All 35 enrolled participants will self-administer 2 mL of Super Liver Liquid Drops daily (2 droppers filled to 1 mL each) in the morning with breakfast for the full 12-week intervention period.

Participants will complete validated questionnaires and self-reported assessments at Baseline, Week 2, Week 4, Week 8, and Week 12 via the Citruslabs study platform. All study activities will be conducted remotely.
Conditions: Gastrointestinal Symptoms
Bloating

Status and Timeline

Status: Active, not recruiting
Last Update Posted: Aug 3, 2026Actual
Start Date: Jun 24, 2026Actual
Primary Completion Date: Sep 2026Estimated
Completion Date

Participation Criteria

Ages Eligible for Study: Adult (18-64)Older Adult (65+)
Sexes Eligible for Study: All
Accepts Healthy Volunteers?: Yes
Eligibility Criteria: Inclusion Criteria:

Be male or female.

Be aged 30-65 years (inclusive) at the time of enrollment.

Over the past four weeks, has had concerns regarding low energy levels and at least two of the following: Bloating, Digestion, Irregular Bowel movements, Brain fog.

Anyone who is generally healthy - does not live with any uncontrolled chronic disease.

Willing and able to follow the study protocol as described.

Willing to maintain their current diet, exercise routine, and sleep patterns, for the duration of the trial.

If taking other over-the-counter supplements or herbal remedies is willing to maintain this routine without introducing any other new products for the study duration.

Resides in the United States.

Willing to follow the study protocol as described.

Exclusion Criteria:

Known allergy or sensitivity to any of the study product ingredients (milk thistle, dandelion, yellow dock, turmeric, ginger, chicory/inulin, berberine).

Known history of severe digestive disorders like acid reflux, Irritable Bowel Syndrome (IBS), Irritable Bowel Disease (IBD), Crohn's disease, or gastrointestinal tract surgeries.

Known history of gallbladder disease or bile duct obstruction.

Has a chronic health condition that could impact participation in this study, such as oncological or psychiatric disorders.

Has a planned surgery in the next 12 weeks.

Currently pregnant, breastfeeding, or planning to become pregnant during the study period.

Known history of substance abuse.

Currently, or was in the past 3 months, a smoker.

Currently participating in or planning to participate in another research study during the study period.

Study Plan

Study Type: Interventional
Phase: Not Applicable
Enrollment: 35Actual
Primary Purpose: Treatment
Allocation: N/A
Interventional Model: Single Group Assignment
Masking: None (Open Label)

Contacts and Locations

Central Contacts: No data available
Locations: Citruslabs

Overview

Status and Timeline

Participation Criteria

Study Plan

Contacts and Locations

Similar Studies